MedX Health Corp Reports Third Quarter 2009 Financial Results

Chief Financial Officer Recently Left the Company

MISSISSAUGA, ON, Nov. 30 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced its results for the quarter ended September 30, 2009. Additionally, Bill Ford, Chief Financial Officer left the company to pursue other opportunities. The company is interviewing replacement Chief Financial Officer candidates.

Revenue for the quarter ended September 30, 2009 was $82,594, a 75.4% decrease over the same period in 2008 where revenue was $335,567. Revenue for the 9 month period ending September 30, 2009 was $540,794, a 39.3% decline from the 9 month period in the prior year. Standard gross margins on sales were consistent with previous quarters, but they were unfavorably impacted by high unabsorbed overhead and labour variances due to extremely low production volumes in the quarter. MedX incurred a loss from continuing operations for the quarter of $379,026 or $0.01 per share compared to a loss of $651,026 or $0.03 per share for the same period in the prior year. The loss for the 9 month period was $1,391,455 in 2009 compared to loss for the 9 month period last year of $2,165,415.

"MedX had a difficult third quarter with a substantial decline in revenue over the same period last year. This quarter's results reflect the temporary drop in sales due to the recovering worldwide economy, as well as our new distributors internationally registering products and ordering demonstration equipment, while our key partner in the North American market, Rich-Mar, is busy preparing for the launch of our integrated technology into their existing products," said Steven Guillen, chief executive officer and president of MedX Health. "These new partnerships will begin to generate revenue in the final quarter of 2009 and increasingly so in 2010."

    
    Third Quarter Company Highlights:

    -   Dissolved partnership with Techology4Medicine, a U.S. based dental
        distributorship which did not meet sales targets.

    -   Bill Ford, Chief Financial Officer, left the company to pursue other
        opportunities. The company is interviewing replacement Chief
        Financial Officer candidates.

    -------------------------------------------------------------------------
    Canadian $                                          Q3 2009      Q3 2008
    -------------------------------------------------------------------------
    Revenue                                              82,594      335,567
    -------------------------------------------------------------------------
    Gross Margin %                                        26.8%        54.6%
    -------------------------------------------------------------------------
    Loss from continued operations                     (379,026)    (651,026)
    -------------------------------------------------------------------------
    Loss from discontinued operations                         0       (8,290)
    -------------------------------------------------------------------------
    Loss for the period                                (379,026)    (659,346)
    -------------------------------------------------------------------------
    Weighted Average no. of shares
     outstanding-basic                               27,128,527   24,822,776
    -------------------------------------------------------------------------
    Loss per Common Share-basic and diluted              ($0.01)      ($0.03)
    -------------------------------------------------------------------------
    

About MedX Health Corp.

MedX is a leading North American developer and manufacturer of low level laser and light medical devices for the drug free and non-invasive treatment of tissue damage and pain in numerous medical settings including dental, rehabilitation and wound care. MedX is the world's only company focusing on developing and delivering a broad cross-section of technologies and products involved in healing using light therapy. MedX is committed to advocating for, the bringing of non-invasive, drug-free healing nature of light to people seeking relief from pain and other physical ailments.

MedX's strategy is to build upon its success in bringing relief of conditions in a non-pharmacologic manner in the rehabilitation market through key partnerships, acquisitions, strong patent protection as well as developing and commercializing advanced products in the dental and wound-care markets that will position the company to increase revenue. In addition, MedX plans to accelerate the development of a new product aimed at the rapidly-growing wound care market: its "Photobandage(TM)", a bandage technology that allows a wound to be bathed in light, designed to enhance the healing process. The Company intends to license this new technology to one or more major wound care companies for further development of marketing and sales.

Brand products are US FDA approved, Health Canada cleared, and CE Marked and are produced in an ISO 9001 and 13485 certified manufacturing and testing facility. For a complete profile of MedX Health Corp. and its products visit www.medXhealth.com

    
    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.
    

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Such forward-looking information may include statements regarding the Company's future plans, objectives, performance, growth, profits, operating expenses or its underlying assumptions. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedX to be materially different from those expressed or implied by such forward-looking information, including uncertainty of successful development of new products, uncertainty of successful manufacturing or marketing of products, uncertainty of commercial acceptance of products, uncertainty concerning governmental regulation, dependency on key employees and relationships, rapid technological changes, foreign currency fluctuations. MedX does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

%SEDAR: 00017466E

SOURCE MedX Health Corp.

For further information: For further information: Contacts: Investors: Steve Guillen, President and Chief Executive Officer, MedX Health Corp., Phone: (905) 826-0766, info@medxhealth.com; Media: Terri Clevenger, Continuum Health Communications, Phone (203) 227-0209, Email: tclevenger@continuumhealthcom.com

Organization Profile

MedX Health Corp.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890